| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0015 | 1 |